Browse the full insider trade history of Evommune, Inc., a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €738m. The latest transaction was disclosed on 1 June 2026 (Levée d'options). Among the most active insiders: Carver Kyle. The full history is openly available.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€636,992
2 ops.
Sell Volume
39Σ signal
Buys ·€636,992 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.